Elevation Oncology Inc. Made Headway
Fri, May 26, 2023 at 07:51 PM
Elevation Oncology Inc. (ELEV:NASDAQ) soared at $5.02, a gain of 66.8%. On Fri, May 26, 2023, ELEV:NASDAQ touched a New 2-Week Intraday High of $5.89. The stock got featured on our News Catalysts scanner on Mon, May 15, 2023 at 07:45 AM in the 'EARNINGS' category. From Fri, May 12, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
About Elevation Oncology Inc. (ELEV:NASDAQ)
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations.
Top 10 Gainers:
- Landos Biopharma Inc. (LABP:NASDAQ), 831.96%
- Verastem, Inc. (VSTM:NASDAQ), 125.55%
- Elevation Oncology Inc. (ELEV:NASDAQ), 66.78%
- Presto Automation Inc Com (PRST:NASDAQ), 63.93%
- Appreciate Holdings Inc Cl A (SFR:NASDAQ), 59.62%
- Bright Health Group Inc. (BHG:NYSE), 45.85%
- Alarum Technologies Ltd Sponsored ADR (ALAR:NASDAQ), 44.5%
- Peraso Inc. (PRSO:NASDAQ), 40.82%
- Annexon Inc. (ANNX:NASDAQ), 35.71%
- Rigetti Computing Inc. (RGTI:NASDAQ), 34.25%